Effects of acute dopamine precusor depletion on immediate reward selection bias and working memory depend on catechol-o-methyltransferase genotype

Journal of Cognitive Neuroscience

Volumn 25, Issue 12, 2013, Pages 2061-2071

  Kelm, Mary Katherine ^a   Boettiger, Charlotte A ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CATECHOL METHYLTRANSFERASE; DOPAMINE; PHENYLALANINE; TYROSINE;

ADULT; ARTICLE; BEVERAGE; BLOOD PRESSURE; CONTROLLED STUDY; GENOTYPE; HUMAN; MALE; MOLECULAR INTERACTION; MOOD; NORMAL HUMAN; PRIORITY JOURNAL; REWARD; SIGNAL TRANSDUCTION; TASK PERFORMANCE; WORKING MEMORY;

ADULT; CATECHOL O-METHYLTRANSFERASE; DOPAMINE; DOUBLE-BLIND METHOD; GENOTYPE; HUMANS; INDIVIDUALITY; MALE; MEMORY, SHORT-TERM; PSYCHOMOTOR PERFORMANCE; REACTION TIME; REWARD; YOUNG ADULT;

EID: 84886705636     PISSN: 0898929X     EISSN: 15308898     Source Type: Journal    
DOI: 10.1162/jocn_a_00464     Document Type: Article

References (71)

1. Acheson, A., & de Wit, H. (2008). Bupropion improves attention but does not affect impulsive behavior in healthy young adults. Experimental and Clinical Psychopharmacology, 16, 113-123.
2. Altamirano, L. J., Fields, H. L., D'Esposito, M., & Boettiger, C. A. 2011. Interaction between family history of alcoholism and locus of control in the opioid regulation of impulsive responding under the influence of alcohol. Alcoholism: Clinical and Experimental Research, 35, 1905-1914.
3. Barratt, E. S. (1994). Impulsiveness and aggression. In Violence and mental disorder: Developments in risk assessment (pp. 61-79). Chicago: University of Chicago Press.
4. Barratt, W. (2006). The Barratt simplified measure of social status (BSMSS) measuring SES. Unpublished manuscript, Indiana State University.
5. Beck, A. T., & Steer, R. A. (1987). Manual for the Revised Beck Depression Inventory. San Antonio, TX: Psychological Corporation.
6. Becker, J. B. (1990). Estrogen rapidly potentiates amphetamineinduced striatal dopamine release and rotational behavior during microdialysis. Neuroscience Letters, 118, 169-171.
7. Bilder, R. M., Volavka, J., Lachman, H. M., & Grace, A. A. (2004). The catechol-O-methyltransferase polymorphism: Relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes. Neuropsychopharmacology, 29, 1943-1961.
8. Boettiger, C. A., Mitchell, J. M., Tavares, V. C., Robertson, M., Joslyn, G., D'Esposito, M., et al. (2007). Immediate reward bias in humans: Fronto-parietal networks and a role for the catechol-O-methyltransferase 158(Val/ Val) genotype. Journal of Neuroscience, 27, 14383-14391.
9. Booij, L., Van der Does, A. J., & Riedel, W. J. (2003). Monoamine depletion in psychiatric and healthy populations: Review. Molecular Psychiatry, 8, 951-973.
10. Butcher, J., Graham, J., Williams, C., & Ben-Porath, Y. (1990). Development and use of the MMPI-2 content scales (p. 196). Minneapolis, MN: University of Minnesota Press.
11. Chen, J., Lipska, B. K., Halim, N., Ma, Q. D., Matsumoto, M., Melhem, S., et al. (2004). Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): Effects on mRNA, protein, and enzyme activity in postmortem human brain. American Journal of Human Genetics, 75, 807-821.
12. Cohen, J. D., Braver, T. S., & Brown, J. W. (2002). Computational perspectives on dopamine function in prefrontal cortex. Current Opinion in Neurobiology, 12, 223-229.
13. Cools, R., & D'Esposito, M. (2011). Inverted-U-shaped dopamine actions on human working memory and cognitive control. Biological Psychiatry, 69, e113-e125.
14. Cools, R., Miyakawa, A., Sheridan, M., & D'Esposito, M. (2010). Enhanced frontal function in Parkinson's disease. Brain, 133, 225-233.
15. Crofts, H. S., Dalley, J. W., Collins, P., Van Denderen, J. C., Everitt, B. J., Robbins, T. W., et al. (2001). Differential effects of 6-OHDA lesions of the frontal cortex and caudate nucleus on the ability to acquire an attentional set. Cerebral Cortex, 11, 1015-1026.
16. de Wit, H., Enggasser, J. L., & Richards, J. B. (2002). Acute administration of d-amphetamine decreases impulsivity in healthy volunteers. Neuropsychopharmacology, 27, 813-825.
17. Doya, K. (2008). Modulators of decision making. Nature Neuroscience, 11, 410-416.
18. Dwoskin, L. P., Rauhut, A. S., King-Pospisil, K. A., & Bardo, M. T. 2006. Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent. CNS Drug Reviews, 12, 178-207.
19. Farrell, S. M., Tunbridge, E. M., Braeutigam, S., & Harrison, P. J. (2012). COMT Val(158)Met genotype determines the direction of cognitive effects produced by catechol-Omethyltransferase inhibition. Biological Psychiatry, 71, 538-544.
20. Gijsman, H. J., Scarna, A., Harmer, C. J., McTavish, S. B., Odontiadis, J., Cowen, P. J., et al. (2002). A dose-finding study on the effects of branch chain amino acids on surrogate markers of brain dopamine function. Psychopharmacology (Berlin), 160, 192-197.
21. Gogos, J. A., Morgan, M., Luine, V., Santha, M., Ogawa, S., Pfaff, D., et al. (1998). Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proceedings of the National Academy of Sciences, U.S.A., 95, 9991-9996.
22. Goldman-Rakic, P. S., Muly, E. C., III, & Williams, G. V. (2000). D(1) receptors in prefrontal cells and circuits. Brain Research. Brain Research Reviews, 31, 295-301.
23. Gray, J. R., Chabris, C. F., & Braver, T. S. (2003). Neural mechanisms of general fluid intelligence. Nature Neuroscience, 6, 316-322.
24. Hamidovic, A., Kang, U. J., & de Wit, H. (2008). Effects of low to moderate acute doses of pramipexole on impulsivity and cognition in healthy volunteers. Journal of Clinical Psychopharmacology, 28, 45-51.
25. Harmer, C. J., McTavish, S. F., Clark, L., Goodwin, G. M., & Cowen, P. J. (2001). Tyrosine depletion attenuates dopamine function in healthy volunteers. Psychopharmacology (Berlin), 154, 105-111.
26. Harrison, B. J., Olver, J. S., Norman, T. R., Burrows, G. D., Wesnes, K. A., & Nathan, P. J. (2004). Selective effects of acute serotonin and catecholamine depletion on memory in healthy women. Journal of Psychopharmacology, 18, 32-40.
27. Hollingshead, A. (1975). Four factor index of social status. New Haven, CT: Yale University.
28. Jacobs, E., & D'Esposito, M. (2011). Estrogen shapes dopaminedependent cognitive processes: Implications for women's health. Journal of Neuroscience, 31, 5286-5293.
29. Kaenmaki, M., Tammimaki, A., Myohanen, T., Pakarinen, K., Amberg, C., Karayiorgou, M., et al. (2010). Quantitative role of COMT in dopamine clearance in the prefrontal cortex of freely moving mice. Journal of Neurochemistry, 114, 1745-1755.
30. Karobath, M., & Baldessarini, R. J. (1972). Formation of catechol compounds from phenylalanine and tyrosine with isolated nerve endings. Nature: New Biology, 236, 206-208.
31. Karoum, F., Chrapusta, S. J., & Egan, M. F. (1994). 3-Methoxytyramine is the major metabolite of released dopamine in the rat frontal cortex: Reassessment of the effects of antipsychotics on the dynamics of dopamine release and metabolism in the frontal cortex, nucleus accumbens, and striatum by a simple two pool model. Journal of Neurochemistry, 63, 972-979.
32. Kayser, A. S., Allen, D. C., Navarro-Cebrian, A., Mitchell, J. M., & Fields, H. L. (2012). Dopamine, corticostriatal connectivity, and intertemporal choice. Journal of Neuroscience, 32, 9402-9409.
33. Kritzer, M. F., & Kohama, S. G. (1998). Ovarian hormones influence the morphology, distribution, and density of tyrosine hydroxylase immunoreactive axons in the dorsolateral prefrontal cortex of adult rhesus monkeys. Journal of Comparative Neurology, 395, 1-17.
34. Lachman, H. M., Papolos, D. F., Saito, T., Yu, Y. M., Szumlanski, C. L., & Weinshilboum, R. M. (1996). Human catechol-Omethyltransferase pharmacogenetics: Description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics, 6, 243-250.
35. Lang, U. E., Bajbouj, M., Sander, T., & Gallinat, J. (2007). Gender-dependent association of the functional catechol-Omethyltransferase Val158Met genotype with sensation seeking personality trait. Neuropsychopharmacology, 32, 1950-1955.
36. Leyton, M., Dagher, A., Boileau, I., Casey, K., Baker, G. B., Diksic, M., et al. (2004). Decreasing amphetamine-induced dopamine release by acute phenylalanine/tyrosine depletion: A PET/[11C]raclopride study in healthy men. Neuropsychopharmacology, 29, 427-432.
37. Mann, R. E., Sobell, L. C., Sobell, M. B., & Pavan, D. (1985). Reliability of a family tree questionnaire for assessing family history of alcohol problems. Drug and Alcohol Dependence, 15, 61-67.
38. McNair, D. M., Lorr, M., & Droppleman, L. F. (1971). Manual for the profile of mood states. San Diego, CA: Educational and Industrial Testing Services.
39. McTavish, S. F., Callado, L., Cowen, P. J., & Sharp, T. (1999). Comparison of the effects of alpha-methyl-p-tyrosine and a tyrosine-free amino acid load on extracellular noradrenaline in the rat hippocampus in vivo. Journal of Psychopharmacology, 13, 379-384.
40. McTavish, S. F., Cowen, P. J., & Sharp, T. (1999). Effect of a tyrosine-free amino acid mixture on regional brain catecholamine synthesis and release. Psychopharmacology (Berlin), 141, 182-188.
41. McTavish, S. F., McPherson, M. H., Harmer, C. J., Clark, L., Sharp, T., Goodwin, G. M., et al. (2001). Antidopaminergic effects of dietary tyrosine depletion in healthy subjects and patients with manic illness. British Journal of Psychiatry, 179, 356-360.
42. Mehta, M. A., Gumaste, D., Montgomery, A. J., McTavish, S. F., & Grasby, P. M. (2005). The effects of acute tyrosine and phenylalanine depletion on spatial working memory and planning in healthy volunteers are predicted by changes in striatal dopamine levels. Psychopharmacology (Berlin), 180, 654-663.
43. Meyer-Lindenberg, A., Kohn, P. D., Kolachana, B., Kippenhan, S., McInerney-Leo, A., Nussbaum, R., et al. (2005). Midbrain dopamine and prefrontal function in humans: Interaction and modulation by COMT genotype. Nature Neuroscience, 8, 594-596.
44. Meyer-Lindenberg, A., Straub, R. E., Lipska, B. K., Verchinski, B. A., Goldberg, T., Callicott, J. H., et al. (2007). Genetic evidence implicating DARPP-32 in human frontostriatal structure, function, and cognition. Journal of Clinical Investigation, 117, 672-682.
45. Mitchell, J. M., Fields, H. L., D'Esposito, M., & Boettiger, C. A. 2005. Impulsive responding in alcoholics. Alcoholism: Clinical and Experimental Research, 29, 2158-2169.
46. Moja, E. A., Lucini, V., Benedetti, F., & Lucca, A. (1996). Decrease in plasma phenylalanine and tyrosine after phenylalanine-tyrosine free amino acid solutions in man. Life Science, 58, 2389-2395.
47. Montgomery, A. J., McTavish, S. F., Cowen, P. J., & Grasby, P. M. 2003. Reduction of brain dopamine concentration with dietary tyrosine plus phenylalanine depletion: An [11C] raclopride PET study. American Journal of Psychiatry, 160, 1887-1889.
48. Nagano-Saito, A., Leyton, M., Monchi, O., Goldberg, Y. K., He, Y., & Dagher, A. (2008). Dopamine depletion impairs frontostriatal functional connectivity during a set-shifting task. Journal of Neuroscience, 28, 3697-3706.
49. Palmatier, M. A., Kang, A. M., & Kidd, K. K. (1999). Global variation in the frequencies of functionally different catechol-Omethyltransferase alleles. Biological Psychiatry, 46, 557-567.
50. Palmour, R. M., Ervin, F. R., Baker, G. B., & Young, S. N. (1998). An amino acid mixture deficient in phenylalanine and tyrosine reduces cerebrospinal fluid catecholamine metabolites and alcohol consumption in vervet monkeys. Psychopharmacology (Berlin), 136, 1-7.
51. Paloyelis, Y., Asherson, P., Mehta, M. A., Faraone, S. V., & Kuntsi, J. (2010). DAT1 and COMT effects on delay discounting and trait impulsivity in male adolescents with attention deficit/hyperactivity disorder and healthy controls. Neuropsychopharmacology, 35, 2414-2426.
52. Pap, D., Gonda, X., Molnar, E., Lazary, J., Benko, A., Downey, D., et al. (2012). Genetic variants in the catechol-Omethyltransferase gene are associated with impulsivity and executive function: Relevance for major depression. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 159B, 928-940.
53. Pietras, C. J., Cherek, D. R., Lane, S. D., Tcheremissine, O. V., & Steinberg, J. L. (2003). Effects of methylphenidate on impulsive choice in adult humans. Psychopharmacology (Berlin), 170, 390-398.
54. Pine, A., Shiner, T., Seymour, B., & Dolan, R. J. (2010). Dopamine, time, and impulsivity in humans. Journal of Neuroscience, 30, 8888-8896.
55. Qian, Q., Wang, Y., Zhou, R., Li, J., Wang, B., Glatt, S., et al. 2003. Family-based and case-control association studies of catechol-O-methyltransferase in attention deficit hyperactivity disorder suggest genetic sexual dimorphism. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 118B, 103-109.
56. Rotter, J. B. (1966). Generalized expectancies for internal versus external control of reinforcement. Psychological Monographs, 80, 1-28.
57. Ruhe, H. G., Mason, N. S., & Schene, A. H. (2007). Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: A meta-analysis of monoamine depletion studies. Molecular Psychiatry, 12, 331-359.
58. Saunders, J. B., Aasland, O. G., Babor, T. F., de la Fuente, J. R., & Grant, M. (1993). Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption-II. Addiction, 88, 791-804.
59. Sawaguchi, T., & Goldman-Rakic, P. S. (1991). D1 dopamine receptors in prefrontal cortex: Involvement in working memory. Science, 251, 947-950.
60. Sheehan, B. D., Tharyan, P., McTavish, S. F., Campling, G. M., & Cowen, P. J. (1996). Use of a dietary manipulation to deplete plasma tyrosine and phenylalanine in healthy subjects. Journal of Psychopharmacology, 10, 231-234.
61. Smith, C. T., & Boettiger, C. A. (2012). Age modulates the effect of COMT genotype on delay discounting behavior. Psychopharmacology (Berlin), 222, 609-617.
62. Spielberger, C. (1985). Assessment of state and trait anxiety: Conceptual and methodological issues. Southern Psychologist, 2, 6-16.
63. Stelzel, C., Basten, U., Montag, C., Reuter, M., & Fiebach, C. J. 2009. Effects of dopamine-related gene-gene interactions on working memory component processes. European Journal of Neuroscience, 29, 1056-1063.
64. Tan, H. Y., Chen, A. G., Kolachana, B., Apud, J. A., Mattay, V. S., Callicott, J. H., et al. (2012). Effective connectivity of AKT1-mediated dopaminergic working memory networks and pharmacogenetics of anti-dopaminergic treatment. Brain, 135, 1436-1445.
65. Tarter, R. E. (1990). Evaluation and treatment of adolescent substance abuse: A decision tree method. American Journal of Drug & Alcohol Abuse, 16, 1-46.
66. Tunbridge, E. M. (2010). The catechol-O-methyltransferase gene: Its regulation and polymorphisms. International Review of Neurobiology, 95, 7-27.
67. Tunbridge, E. M., Bannerman, D. M., Sharp, T., & Harrison, P. J. 2004. Catechol-O-methyltransferase inhibition improves set-shifting performance and elevates stimulated dopamine release in the rat prefrontal cortex. Journal of Neuroscience, 24, 5331-5335.
68. Wallace, M. (1956). Future time perspective in schizophrenia. Journal of Abnormal Psychology, 52, 240-245.
69. Williams, G. V., & Castner, S. A. (2006). Under the curve: Critical issues for elucidating D1 receptor function in working memory. Neuroscience, 139, 263-276.
70. Wu, K., O'Keeffe, D., Politis, M., O'Keeffe, G. C., Robbins, T. W., Bose, S. K., et al. (2012). The catechol-O-methyltransferase Val158Met polymorphism modulates fronto-cortical dopamine turnover in early Parkinson's disease: A PET study. Brain, 135, 2449-2457.
71. Yavich, L., Forsberg, M. M., Karayiorgou, M., Gogos, J. A., & Mannisto, P. T. (2007). Site-specific role of catechol-Omethyltransferase in dopamine overflow within prefrontal cortex and dorsal striatum. Journal of Neuroscience, 27, 10196-10209.